世界の酵素ポリADPリボースポリメラーゼ（PARP）阻害剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4191 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、酵素ポリADPリボースポリメラーゼ（PARP）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ニラパリブ（ゼジュラ）、オラパリブ（リンパルザ）、ルカパリブ（ルブラカ）、タラゾパリブ（タルゼンナ））、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・酵素ポリADPリボースポリメラーゼ（PARP）阻害剤の市場動向 ・企業の競争状況、市場シェア ・酵素ポリADPリボースポリメラーゼ（PARP）阻害剤の種類別市場規模と予測2016-2027（ニラパリブ（ゼジュラ）、オラパリブ（リンパルザ）、ルカパリブ（ルブラカ）、タラゾパリブ（タルゼンナ）） ・酵素ポリADPリボースポリメラーゼ（PARP）阻害剤の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局） ・酵素ポリADPリボースポリメラーゼ（PARP）阻害剤の北米市場規模2016-2027（アメリカ、カナダ） ・酵素ポリADPリボースポリメラーゼ（PARP）阻害剤の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・酵素ポリADPリボースポリメラーゼ（PARP）阻害剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・酵素ポリADPリボースポリメラーゼ（PARP）阻害剤の中南米市場規模2016-2027（メキシコ、ブラジル） ・酵素ポリADPリボースポリメラーゼ（PARP）阻害剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AstraZeneca、Pfizer、Takeda、Abbvie、Clovis、BeiGene、Hansoh、Jeil、Oncology、Shin Poong） ・結論

Market Analysis and Insights: Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market
The global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor market.

Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Scope and Market Size
Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Niraparib (Zejula)
Olaparib (Lynparza)
Rucaparib (Rubraca)
Talazoparib (Talzenna)

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca
Pfizer
Takeda
Abbvie
Clovis
BeiGene
Hansoh
Jeil
Oncology
Shin Poong

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Niraparib (Zejula)
1.2.3 Olaparib (Lynparza)
1.2.4 Rucaparib (Rubraca)
1.2.5 Talazoparib (Talzenna)
1.3 Market by Application
1.3.1 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Perspective (2016-2027)
2.2 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Growth Trends by Regions
2.2.1 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Historic Market Share by Regions (2016-2021)
2.2.3 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Forecasted Market Size by Regions (2022-2027)
2.3 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Industry Dynamic
2.3.1 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Trends
2.3.2 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Drivers
2.3.3 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Challenges
2.3.4 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Players by Revenue
3.1.1 Global Top Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Players by Revenue (2016-2021)
3.1.2 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Players (2016-2021)
3.2 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue
3.4 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Concentration Ratio
3.4.1 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue in 2020
3.5 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Key Players Head office and Area Served
3.6 Key Players Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product Solution and Service
3.7 Date of Enter into Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Breakdown Data by Type
4.1 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Historic Market Size by Type (2016-2021)
4.2 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Forecasted Market Size by Type (2022-2027)

5 Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Breakdown Data by Application
5.1 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Historic Market Size by Application (2016-2021)
5.2 Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size (2016-2027)
6.2 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type
6.2.1 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2016-2021)
6.2.2 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2022-2027)
6.2.3 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2016-2027)
6.3 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application
6.3.1 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2016-2021)
6.3.2 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2022-2027)
6.3.3 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2016-2027)
6.4 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country
6.4.1 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2016-2021)
6.4.2 North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size (2016-2027)
7.2 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type
7.2.1 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2016-2021)
7.2.2 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2022-2027)
7.2.3 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2016-2027)
7.3 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application
7.3.1 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2016-2021)
7.3.2 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2022-2027)
7.3.3 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2016-2027)
7.4 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country
7.4.1 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2016-2021)
7.4.2 Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size (2016-2027)
8.2 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type
8.2.1 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2016-2027)
8.3 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application
8.3.1 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2016-2027)
8.4 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Region
8.4.1 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size (2016-2027)
9.2 Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type
9.2.1 Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2016-2021)
9.2.2 Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2022-2027)
9.2.3 Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2016-2027)
9.3 Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application
9.3.1 Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2016-2021)
9.3.2 Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2022-2027)
9.3.3 Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2016-2027)
9.4 Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country
9.4.1 Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2016-2021)
9.4.2 Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size (2016-2027)
10.2 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type
10.2.1 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2016-2027)
10.3 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application
10.3.1 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2016-2027)
10.4 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country
10.4.1 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Introduction
11.1.4 AstraZeneca Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Introduction
11.2.4 Pfizer Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Takeda
11.3.1 Takeda Company Details
11.3.2 Takeda Business Overview
11.3.3 Takeda Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Introduction
11.3.4 Takeda Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021)
11.3.5 Takeda Recent Development
11.4 Abbvie
11.4.1 Abbvie Company Details
11.4.2 Abbvie Business Overview
11.4.3 Abbvie Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Introduction
11.4.4 Abbvie Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021)
11.4.5 Abbvie Recent Development
11.5 Clovis
11.5.1 Clovis Company Details
11.5.2 Clovis Business Overview
11.5.3 Clovis Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Introduction
11.5.4 Clovis Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021)
11.5.5 Clovis Recent Development
11.6 BeiGene
11.6.1 BeiGene Company Details
11.6.2 BeiGene Business Overview
11.6.3 BeiGene Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Introduction
11.6.4 BeiGene Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021)
11.6.5 BeiGene Recent Development
11.7 Hansoh
11.7.1 Hansoh Company Details
11.7.2 Hansoh Business Overview
11.7.3 Hansoh Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Introduction
11.7.4 Hansoh Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021)
11.7.5 Hansoh Recent Development
11.8 Jeil
11.8.1 Jeil Company Details
11.8.2 Jeil Business Overview
11.8.3 Jeil Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Introduction
11.8.4 Jeil Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021)
11.8.5 Jeil Recent Development
11.9 Oncology
11.9.1 Oncology Company Details
11.9.2 Oncology Business Overview
11.9.3 Oncology Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Introduction
11.9.4 Oncology Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021)
11.9.5 Oncology Recent Development
11.10 Shin Poong
11.10.1 Shin Poong Company Details
11.10.2 Shin Poong Business Overview
11.10.3 Shin Poong Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Introduction
11.10.4 Shin Poong Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021)
11.10.5 Shin Poong Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Niraparib (Zejula)
Table 3. Key Players of Olaparib (Lynparza)
Table 4. Key Players of Rucaparib (Rubraca)
Table 5. Key Players of Talazoparib (Talzenna)
Table 6. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Regions (2016-2021)
Table 10. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Regions (2022-2027)
Table 12. Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Trends
Table 13. Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Drivers
Table 14. Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Challenges
Table 15. Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Restraints
Table 16. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Players (2016-2021)
Table 18. Global Top Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor as of 2020)
Table 19. Ranking of Global Top Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product Solution and Service
Table 23. Date of Enter into Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Type (2016-2021)
Table 27. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Application (2016-2021)
Table 31. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size by Country (2022-2027) & (US$ Million)
Table 63. AstraZeneca Company Details
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product
Table 66. AstraZeneca Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021) & (US$ Million)
Table 67. AstraZeneca Recent Development
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product
Table 71. Pfizer Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. Takeda Company Details
Table 74. Takeda Business Overview
Table 75. Takeda Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product
Table 76. Takeda Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021) & (US$ Million)
Table 77. Takeda Recent Development
Table 78. Abbvie Company Details
Table 79. Abbvie Business Overview
Table 80. Abbvie Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product
Table 81. Abbvie Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021) & (US$ Million)
Table 82. Abbvie Recent Development
Table 83. Clovis Company Details
Table 84. Clovis Business Overview
Table 85. Clovis Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product
Table 86. Clovis Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021) & (US$ Million)
Table 87. Clovis Recent Development
Table 88. BeiGene Company Details
Table 89. BeiGene Business Overview
Table 90. BeiGene Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product
Table 91. BeiGene Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021) & (US$ Million)
Table 92. BeiGene Recent Development
Table 93. Hansoh Company Details
Table 94. Hansoh Business Overview
Table 95. Hansoh Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product
Table 96. Hansoh Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021) & (US$ Million)
Table 97. Hansoh Recent Development
Table 98. Jeil Company Details
Table 99. Jeil Business Overview
Table 100. Jeil Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021) & (US$ Million)
Table 101. Jeil Recent Development
Table 102. Oncology Company Details
Table 103. Oncology Business Overview
Table 104. Oncology Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product
Table 105. Oncology Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021) & (US$ Million)
Table 106. Oncology Recent Development
Table 107. Shin Poong Company Details
Table 108. Shin Poong Business Overview
Table 109. Shin Poong Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Product
Table 110. Shin Poong Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021) & (US$ Million)
Table 111. Shin Poong Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Type: 2020 VS 2027
Figure 2. Niraparib (Zejula) Features
Figure 3. Olaparib (Lynparza) Features
Figure 4. Rucaparib (Rubraca) Features
Figure 5. Talazoparib (Talzenna) Features
Figure 6. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Report Years Considered
Figure 11. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Regions: 2020 VS 2027
Figure 14. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Regions (2022-2027)
Figure 15. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Players in 2020
Figure 16. Global Top Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue in 2020
Figure 18. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Type (2016-2021)
Figure 19. Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Revenue Market Share by Type (2022-2027)
Figure 20. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Type (2016-2027)
Figure 22. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Application (2016-2027)
Figure 23. North America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Country (2016-2027)
Figure 24. United States Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Type (2016-2027)
Figure 28. Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Application (2016-2027)
Figure 29. Europe Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Country (2016-2027)
Figure 30. Germany Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Region (2016-2027)
Figure 40. China Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Type (2016-2027)
Figure 48. Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Application (2016-2027)
Figure 49. Latin America Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Country (2016-2027)
Figure 50. Mexico Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Share by Country (2016-2027)
Figure 56. Turkey Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. AstraZeneca Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021)
Figure 61. Takeda Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021)
Figure 62. Abbvie Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021)
Figure 63. Clovis Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021)
Figure 64. BeiGene Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021)
Figure 65. Hansoh Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021)
Figure 66. Jeil Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021)
Figure 67. Oncology Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021)
Figure 68. Shin Poong Revenue Growth Rate in Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---